Filing Flows

Filing Flows › Medinotec (MDNC) › Q3 FY26

Medinotec (MDNC) Q3 FY26 earnings results (third quarter fiscal 2026)

10-Q filed Jan 9, 2026

Medinotec (MDNC) reported revenue of $2.5M for the third quarter fiscal 2026 (Q3 FY26), -1% from a year earlier and -22% from the quarter before. Operating margin was 21.8%, net earnings $403K (15.9% of revenue).

Revenue$2.5M
Year over year-1%
Quarter over quarter-22%
Operating margin21.8%
Net earnings$403K

Medinotec, Q3 FY26: revenue $2.5M (-1% year over year), operating margin 21.8%, net earnings $403K, operating cash flow $563K. The chart follows the revenue to costs, profit and cash.

Q3 FY26AmountQ/QY/Y
Revenue$2.5M-22%-1%
Gross profit$1.3M-32%+29%
Operating profit$553K+5%+5%
Net earnings$403K+16%+30%
Operating cash flow$563K-54%+352%

What changed

Revenue was $2.5M in Q3 FY26, down 1% year over year and down 22% from the previous quarter. Outside U S A Distribution Agreement Sales was the largest line at 85% of revenue. Inside U S A Internally Designed Manufactured Sales lost $89K year over year (down 41%), 317% of the total change.

Gross margin was 53.1%, up 12.5 points from a year earlier. Operating profit was $553K, a 21.8% margin (up 1.2 points year over year). Operating expenses grew 55% against a revenue fall of 1%. The fastest-growing cost line was Sales & marketing (+649%). Net earnings were $403K, up 30% year over year. The effective tax rate was 25.7%.

Operating cash flow was $563K (up 352% year over year), 140% of net earnings. Non-cash charges added back $8K of depreciation and amortization. Working capital and other items added $152K.

Questions

What was Medinotec's revenue in the third quarter fiscal 2026?

Medinotec (MDNC) reported revenue of $2.5M for the third quarter fiscal 2026 (Q3 FY26), -1% from a year earlier and -22% from the quarter before.

Was Medinotec profitable in the third quarter fiscal 2026?

Operating profit was $553K (21.8% of revenue) and net earnings $403K.

Open the interactive Sankey →

Source: Medinotec 10-Q on SEC EDGAR.